Download by
Scanning QR Code
CN Stock MarketDetailed Quotes
300003 Lepu Medical Technology
Watchlist
16.43
-0.25-1.50%
Market Closed 09/28 15:00 CST
16.69High16.41Low154.85KlotVolume
16.68Open16.68Pre Close255.44MTurnover0.96%Turnover Ratio16.30P/E (TTM)30.90BMarket Cap26.0752wk High14.03P/E (Static)1.88BShares15.5152wk Low1.99P/B26.53BFloat Cap46.12Historical High20.02Limit Up1.61BShs Float2.09Historical Low13.34Limit Down1.68%Amplitude96.24KlotAsk0.34Dividend TTM16.50Avg Price58.61KlotBid2.08%Div YieldTTM100Lot Size
Lepu Medical Technology Key Stats
All
YOY
| (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | (Q3)2022/03/31 | (FY)2021/12/31 | (Q9)2021/09/30 | (Q6)2021/06/30 | (Q3)2021/03/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -19.35%4.3B | -4.39%2.44B | -0.47%10.61B | -10.11%7.76B | -18.20%5.33B | -7.28%2.55B | 32.61%10.66B | 35.19%8.63B | 53.87%6.52B | 64.96%2.75B |
| Operating revenue | -19.35%4.3B | -4.39%2.44B | -0.47%10.61B | -10.11%7.76B | -18.20%5.33B | -7.28%2.55B | 32.61%10.66B | 35.19%8.63B | 53.87%6.52B | 64.96%2.75B |
| Other operating revenue | 27.41%34.1M | ---- | 21.80%56.93M | ---- | -2.75%26.76M | ---- | 0.27%46.74M | ---- | 64.68%27.52M | ---- |
| Total operating cost | -14.75%3.21B | -4.99%1.75B | -3.42%7.93B | -6.90%5.54B | -12.12%3.77B | -0.71%1.84B | 32.54%8.21B | 32.44%5.95B | 54.55%4.29B | 55.25%1.85B |
| Operating cost | -25.30%1.51B | -12.95%805.47M | -4.17%3.98B | -9.51%2.93B | -16.75%2.02B | -4.15%925.27M | 56.63%4.16B | 67.33%3.23B | 96.61%2.43B | 120.18%965.31M |
| Operating tax surcharges | -17.26%45.75M | -7.82%24.99M | 3.24%117.47M | -14.64%80.3M | -28.16%55.3M | -13.80%27.11M | 25.75%113.78M | 32.33%94.07M | 90.41%76.98M | 71.45%31.45M |
| Operating expense | -2.34%803.75M | -6.32%440.81M | -3.58%2.03B | -7.38%1.25B | -14.13%822.98M | -5.89%470.56M | 14.71%2.11B | 7.15%1.35B | 17.40%958.35M | 18.27%500M |
| Administration expense | 3.43%377.65M | 9.83%193.62M | -0.76%742.67M | 0.14%532.71M | 3.42%365.12M | 16.96%176.3M | 23.35%748.34M | -5.07%531.96M | 36.62%353.06M | 20.81%150.73M |
| Financial expense | -45.84%35.78M | 86.06%54.43M | -46.10%92.58M | -41.41%82.47M | -34.44%66.06M | -29.75%29.25M | -35.59%171.76M | -31.89%140.76M | -21.60%100.76M | -33.38%41.64M |
| -Interest expense (Financial expense) | -13.03%86.97M | -2.18%43.47M | -17.38%188.78M | -8.81%157.8M | -12.27%100.01M | -14.68%44.44M | -15.04%228.49M | -18.64%173.04M | -23.76%113.99M | -32.41%52.08M |
| -Interest Income (Financial expense) | -51.52%-62.72M | -123.53%-34.16M | -52.80%-87.99M | -33.18%-63.41M | -39.25%-41.39M | -77.28%-15.28M | -33.42%-57.59M | -38.60%-47.61M | -19.07%-29.73M | 25.38%-8.62M |
| Research and development | 0.40%441.22M | 8.14%229.69M | 5.41%957.06M | 11.14%671.74M | 17.83%439.48M | 28.73%212.39M | 23.34%907.94M | 29.72%604.39M | 25.48%372.98M | 29.40%164.99M |
| Credit Impairment Loss | -70.46%-17.87M | 43.43%-440.48K | -14.62%-34.28M | 13.97%-22.85M | 44.50%-10.48M | 91.40%-778.59K | 20.32%-29.91M | 17.76%-26.56M | 19.12%-18.88M | 27.15%-9.05M |
| Asset Impairment Loss | 2.13%-1.94M | 1,224.97%877.62K | -301.70%-37.95M | 7.69%-2.41M | ---1.98M | -406.34%-78.01K | 54.96%-9.45M | 81.78%-2.61M | ---- | --25.47K |
| Other net revenue | 183.18%26.35M | 149.19%11.66M | 80.63%-59.56M | 78.42%-62.84M | 50.56%-31.68M | -220.23%-23.7M | -201.47%-307.48M | -166.60%-291.21M | 25.94%-64.08M | 227.93%19.72M |
| Fair value change income | 9,139.82%16.27M | 215.65%5.76M | -84.93%4.42M | 94.71%-9.94M | -110.06%-180K | -110.79%-4.98M | -93.51%29.34M | -138.40%-188M | --1.79M | --46.15M |
| Invest income | 42.32%-23.04M | 19.04%-21.54M | 81.02%-75.33M | 50.97%-63.39M | 43.36%-39.94M | 0.74%-26.61M | -158.05%-396.88M | -179.67%-129.29M | -220.95%-70.52M | -348.26%-26.81M |
| -Including: Investment income associates | 63.47%-15.9M | 26.22%-19.82M | 40.34%-90.83M | 37.92%-67.05M | 41.23%-43.52M | 3.24%-26.87M | -6.64%-152.25M | -245.43%-108.01M | -298.38%-74.05M | -204.85%-27.77M |
| Asset deal income | 241.02%1.25M | 1,737.41%1.25M | -99.88%24.27K | -98.53%296.38K | 547.73%367.42K | 22.25%68.19K | 769.66%19.9M | 4,379.56%20.14M | -80.55%56.72K | 58.26%55.78K |
| Other revenue | 151.61%51.67M | 196.89%25.75M | 5.09%83.57M | 0.99%35.45M | -12.52%20.54M | -7.13%8.67M | 29.96%79.52M | -12.41%35.1M | 58.44%23.47M | 216.06%9.34M |
| Operating profit | -27.28%1.11B | 2.24%699.84M | 22.31%2.62B | -9.77%2.16B | -29.30%1.53B | -25.18%684.52M | -0.21%2.14B | 2.60%2.39B | 57.50%2.17B | 100.24%914.88M |
| Add:Non operating Income | 523.82%36.04M | 931.41%33.16M | -77.80%14.13M | -16.81%15.63M | -63.85%5.78M | -29.66%3.22M | -12.59%63.65M | -42.93%18.79M | -41.23%15.98M | -42.62%4.57M |
| Less:Non operating expense | -61.83%3.89M | -75.13%2.05M | -58.96%25.49M | -43.36%15.73M | -1.80%10.19M | 230.19%8.23M | 232.34%62.1M | 119.14%27.78M | -1.89%10.37M | 50.45%2.49M |
| Total profit | -24.96%1.15B | 7.57%730.96M | 21.70%2.61B | -9.43%2.16B | -29.69%1.53B | -25.90%679.51M | -2.59%2.15B | 1.33%2.38B | 56.03%2.17B | 97.96%916.96M |
| Less:Income tax cost | -35.77%147.83M | -4.04%112.64M | 0.37%367.09M | -12.94%319.28M | -35.39%230.15M | -26.33%117.38M | 12.11%365.73M | 8.48%366.75M | 71.21%356.2M | 115.63%159.33M |
| Net profit | -23.05%998.01M | 10.00%618.32M | 26.08%2.24B | -8.79%1.84B | -28.57%1.3B | -25.80%562.13M | -5.15%1.78B | 0.13%2.01B | 53.36%1.82B | 94.60%757.63M |
| Net profit from continuing operation | -23.05%998.01M | 10.00%618.32M | 26.08%2.24B | -8.79%1.84B | -28.57%1.3B | -25.80%562.13M | -5.15%1.78B | 0.13%2.01B | 53.36%1.82B | 94.60%757.63M |
| Less:Minority Profit | 26.39%36.52M | 27.84%21.39M | -31.45%41.88M | -71.75%25.96M | -67.87%28.9M | -46.86%16.73M | -18.70%61.09M | 145.39%91.88M | 106.07%89.92M | 477.05%31.49M |
| Net profit of parent company owners | -24.17%961.49M | 9.45%596.92M | 28.12%2.2B | -5.78%1.81B | -26.53%1.27B | -24.89%545.39M | -4.58%1.72B | -2.63%1.92B | 51.34%1.73B | 89.17%726.14M |
| Earning per share | ||||||||||
| Basic earning per share | -27.46%0.5163 | 4.94%0.3205 | 27.38%1.2223 | -5.24%1.0158 | -26.10%0.7117 | -24.63%0.3054 | -5.37%0.9596 | -3.73%1.072 | 49.42%0.963 | 86.73%0.4052 |
| Diluted earning per share | -26.88%0.5147 | 4.85%0.3177 | 27.49%1.2124 | -4.66%1.0051 | -25.22%0.7039 | -25.22%0.303 | -6.22%0.951 | -5.33%1.0542 | 46.39%0.9413 | 86.73%0.4052 |
| Other composite income | 122.64%54.2M | 128.49%38.89M | -338.76%-403.72M | -359.63%-220.97M | -252.58%-239.45M | -613.24%-136.49M | 36.51%169.09M | 52.00%85.11M | -10.80%156.94M | 145.07%26.59M |
| Other composite income of parent company owners | 128.55%66.34M | 133.26%41.77M | -339.94%-386.24M | -339.93%-215.01M | -247.30%-232.38M | -514.71%-125.59M | 233.69%160.97M | 879.06%89.61M | 37.73%157.75M | 153.20%30.28M |
| Other composite income of minority owners | -71.66%-12.13M | 73.63%-2.88M | -315.44%-17.49M | -32.37%-5.96M | -763.07%-7.07M | -195.84%-10.91M | -89.27%8.12M | -109.61%-4.5M | -101.33%-818.98K | -76.57%-3.69M |
| Total composite income | -0.50%1.05B | 54.41%657.21M | -5.57%1.84B | -23.02%1.62B | -46.39%1.06B | -45.73%425.63M | -2.57%1.95B | 1.53%2.1B | 45.06%1.97B | 137.42%784.22M |
| Total composite income of parent company owners | -0.76%1.03B | 52.14%638.69M | -3.39%1.82B | -20.67%1.6B | -45.02%1.04B | -44.50%419.81M | 1.63%1.88B | 1.44%2.01B | 50.10%1.88B | 131.36%756.42M |
| Total composite income of minority owners | 11.73%24.39M | 217.88%18.52M | -64.76%24.39M | -77.12%19.99M | -75.50%21.83M | -79.05%5.83M | -54.09%69.21M | 3.67%87.38M | -15.17%89.1M | 725.32%27.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.